Literature DB >> 24612910

Emotional functioning of adolescents and adults with congenital heart disease: a meta-analysis.

Jamie L Jackson1, Brian Misiti, Jeffrey A Bridge, Curt J Daniels, Kathryn Vannatta.   

Abstract

OBJECTIVE: This study aimed to quantitatively compare findings of emotional functioning across studies of adolescents and adults with congenital heart disease (CHD) through meta-analysis.
DESIGN: The current meta-analysis included 22 studies of adolescent and adult survivors of CHD who completed measures of emotional functioning. Effect sizes were represented by Hedge's g. Heterogeneity was calculated and possible moderators (i.e., lesion severity, age, study location, study quality) were examined.
RESULTS: Overall, adolescent and adult survivors of CHD did not differ in emotional functioning from healthy controls or normative data. However, significant heterogeneity was found, and there was a trend for degree of lesion severity to moderate emotional functioning. Further analysis of lesion severity indicated that individuals with moderate lesions reported better emotional functioning than controls/normative data. Limitations in existing literature precluded examination of patient age as a moderator. Study location and quality did not explain a significant portion of the variance in effects.
CONCLUSIONS: Findings suggest that differences in emotional functioning may exist across lesion severities, and individuals with moderately severe lesions are emotionally thriving. Given the diversity within CHD lesion classifications, future studies should include other indicators of disease severity, such as measures of morbidity, to determine how disease may affect emotional functioning among survivors of CHD. Furthermore, authors and journals need to ensure that research is reported in enough detail to facilitate meta-analysis, a critically important tool in answering discrepancies in the literature.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Emotional Distress; Emotional Functioning; Meta-Analysis

Mesh:

Year:  2014        PMID: 24612910      PMCID: PMC4145051          DOI: 10.1111/chd.12178

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  52 in total

Review 1.  Congenital heart disease in adults. First of two parts.

Authors:  M E Brickner; L D Hillis; R A Lange
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

Review 2.  Advanced methods in meta-analysis: multivariate approach and meta-regression.

Authors:  Hans C van Houwelingen; Lidia R Arends; Theo Stijnen
Journal:  Stat Med       Date:  2002-02-28       Impact factor: 2.373

3.  A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.

Authors:  Nancy K Grote; Jeffrey A Bridge; Amelia R Gavin; Jennifer L Melville; Satish Iyengar; Wayne J Katon
Journal:  Arch Gen Psychiatry       Date:  2010-10

4.  Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease.

Authors:  M Kamphuis; J Ottenkamp; H W Vliegen; T Vogels; K H Zwinderman; R P Kamphuis; S P Verloove-Vanhorick
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

5.  Quality of life and perceived health status in surviving adults with univentricular heart.

Authors:  Z Saliba; G Butera; D Bonnet; P Bonhoeffer; E Villain; J Kachaner; D Sidi; L Iserin
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

6.  Relation of right ventricular dilation, age of repair, and restrictive right ventricular physiology with patient-reported quality of life in adolescents and adults with repaired tetralogy of fallot.

Authors:  Jimmy C Lu; Timothy B Cotts; Prachi P Agarwal; Anil K Attili; Adam L Dorfman
Journal:  Am J Cardiol       Date:  2010-11-02       Impact factor: 2.778

7.  Anxiety, depressive and somatic symptoms in adults with congenital heart disease.

Authors:  Bahareh Eslami; Orjan Sundin; Gloria Macassa; Hamid Reza Khankeh; Joaquim J F Soares
Journal:  J Psychosom Res       Date:  2012-11-11       Impact factor: 3.006

Review 8.  Consensus-based method for risk adjustment for surgery for congenital heart disease.

Authors:  Kathy J Jenkins; Kimberlee Gauvreau; Jane W Newburger; Thomas L Spray; James H Moller; Lisa I Iezzoni
Journal:  J Thorac Cardiovasc Surg       Date:  2002-01       Impact factor: 5.209

9.  A cross-sectional study of the prevalence of psychopathology in adults with congenital heart disease.

Authors:  David Cox; Glyn Lewis; Graham Stuart; Kieran Murphy
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

10.  Psychological functioning and health-related quality of life (HRQoL) in older patients following percutaneous closure of the secundum atrial septal defect (ASD).

Authors:  Miri Cohen; Mansoor Daniela; Sergey Yalonetsky; Roni Gagin; Avraham Lorber
Journal:  Arch Gerontol Geriatr       Date:  2009-05-12       Impact factor: 3.250

View more
  11 in total

1.  Health and Well-Being in Surviving Congenital Heart Disease Patients: An Umbrella Review With Synthesis of Best Evidence.

Authors:  Lucia Cocomello; Kurt Taylor; Massimo Caputo; Rosie P Cornish; Deborah A Lawlor
Journal:  Front Cardiovasc Med       Date:  2022-06-10

2.  Post-traumatic stress disorder, anxiety, and depression among adults with congenital heart defects.

Authors:  Regina M Simeone; Karrie F Downing; William V Bobo; Scott D Grosse; Amber D Khanna; Sherry L Farr
Journal:  Birth Defects Res       Date:  2021-12-21       Impact factor: 2.661

3.  Limitations, depressive symptoms, and quality of life among a population-based sample of young adults with congenital heart defects.

Authors:  Sherry L Farr; Matthew E Oster; Regina M Simeone; Suzanne M Gilboa; Margaret A Honein
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-03-17

4.  Perceptions of Disease-Related Stress: A Key to Better Understanding Patient-Reported Outcomes Among Survivors of Congenital Heart Disease.

Authors:  Jamie L Jackson; Gina M Gerardo; Curt J Daniels; Kathryn Vannatta
Journal:  J Cardiovasc Nurs       Date:  2017 Nov/Dec       Impact factor: 2.083

5.  Adolescents and Young Adults Living with Congenital Heart Disease: Coping, Stress Reactivity, and Emotional Functioning.

Authors:  Jennifer D Monti; Jamie L Jackson; Kathryn Vannatta
Journal:  J Clin Psychol Med Settings       Date:  2018-12

6.  The Center for Epidemiologic Studies Depression Scale is an adequate screening instrument for depression and anxiety disorder in adults with congential heart disease.

Authors:  Ju Ryoung Moon; June Huh; Jinyoung Song; I-Seok Kang; Seung Woo Park; Sung-A Chang; Ji-Hyuk Yang; Tae-Gook Jun
Journal:  Health Qual Life Outcomes       Date:  2017-09-05       Impact factor: 3.186

7.  Quality of life and health status of hospitalized adults with congenital heart disease in Vietnam: a cross-sectional study.

Authors:  Thanh-Huong Truong; Ngoc-Thanh Kim; Mai-Ngoc Thi Nguyen; Doan-Loi Do; Hong Thi Nguyen; Thanh-Tung Le; Hong-An Le
Journal:  BMC Cardiovasc Disord       Date:  2021-05-05       Impact factor: 2.298

8.  Sense of coherence and quality of life in adolescents with heart disease.

Authors:  Virgínia Menezes Coutinho; Gabriele Lima de Araújo; Maria Carlla Aroucha Lyra; Aronita Rosenblatt; Mônica Vilela Heimer
Journal:  Rev Paul Pediatr       Date:  2022-05-06

9.  Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.

Authors:  Kate H Marshall; Yves D'Udekem; Gary F Sholler; Alexander R Opotowsky; Daniel S J Costa; Louise Sharpe; David S Celermajer; David S Winlaw; Jane W Newburger; Nadine A Kasparian
Journal:  J Am Heart Assoc       Date:  2020-03-16       Impact factor: 5.501

10.  Brain volumes in adults with congenital heart disease correlate with executive function abilities.

Authors:  Nadja Naef; Ladina Schlosser; Peter Brugger; Matthias Greutmann; Angela Oxenius; Flavia Wehrle; Raimund Kottke; Beatrice Latal; Ruth Tuura O'Gorman
Journal:  Brain Imaging Behav       Date:  2021-01-30       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.